Seres Therapeutics, Inc.MCRB

Seres Therapeutics, Inc. (Nasdaq: MCRB) is a clinical-stage biotechnology company developing novel live biotherapeutics, with a focus on therapies that allow patients to maintain their cancer care, and that treat inflammatory and immune diseases. The Company led the development and FDA approval of VOWST, the first orally administered microbiome therapeutic, which was subsequently divested to Nestlé Health.

serestherapeutics.com